Identification of an irreversible PPARγ antagonist with potent anticancer activity
Abstract Melanoma is responsible for most skin cancer deaths, and its incidence continues to rise year after year. Different treatment options have been developed for melanoma depending on the stage of the disease. Despite recent advances in immuno‐ and targeted therapies, advanced melanoma remains...
Main Authors: | Youyi Peng, Qiang Zhang, Robert M. Zielinski, Richard D. Howells, William J. Welsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.693 |
Similar Items
-
PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01) -
BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model
by: Na Yuan, et al.
Published: (2018-04-01) -
Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity
by: Shi Feng, et al.
Published: (2016-09-01) -
PPARα and PPARγ as main regulators of fatty acid metabolism
by: Mirosław Kucharski, et al.
Published: (2018-10-01) -
Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
by: Xinni Xie, et al.
Published: (2017-05-01)